Trials / Sponsors / Incyte Biosciences Japan GK
Incyte Biosciences Japan GK
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participa Chronic Graft-versus-host-disease | Phase 3 | 2024-07-30 |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of INCB054707 Healthy Participants | Phase 1 | 2021-10-21 |
| Terminated | To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550 Solid Tumors | Phase 1 | 2021-02-03 |
| Active Not Recruiting | To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Part Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma | Phase 1 / Phase 2 | 2020-12-15 |
| Completed | Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CIT Lymphoma | Phase 2 | 2020-09-30 |
| Completed | A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 | 2019-07-22 |